Navigation Links
Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
Date:4/20/2012

EAST BRUNSWICK, N.J., April 20, 2012 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that the Company's first quarter financial results will be released prior to the open of the market on Wednesday, May 9, 2012.
Savient executive management will host a conference call beginning at 9:00 a.m. Eastern Time on May 9, 2012, to discuss these results and to answer questions.

To participate by telephone, please dial 866-393-1565 (Domestic) or 253-237-1151 (International). The conference ID number is 72346185.  The live and archived webcast can be accessed on the investor relations section of the Savient website at www.savient.com.  A telephone replay will be available from 12:00 p.m. Eastern Time on May 9, 2012, through 12:00 a.m. Eastern Time on May 16, 2012, by dialing 855-859-2056 (Domestic) or 404-537-3406 (International) and entering conference ID number 72346185.

ABOUT SAVIENT PHARMACEUTICALS, INC.Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA® (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA and its uses from Duke University ("Duke") and Mountain View Pharmaceuticals, Inc. ("MVP"). Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology used in the manufacture of KRYSTEXXA. MVP and Duke have been granted U.S. and foreign patents disclosing and claiming the licensed technology and, in addition, Savient owns or co-owns U.S. and foreign patents and patent applications, which collectively form a broad portfolio of patents covering the composition, manufacture and methods of use and administration of KRYSTEXXA. Savient also manufactures and supplies Oxandrin® (oxandrolone tablets, USP) CIII in the U.S. For more information, please visit the Company's website at www.savient.com.

SVNT-IContact: Mary Coleman

Carney Noensie Savient Pharmaceuticals, Inc.

Burns McClellan information@savient.com

cnoensie@burnsmc.com (732) 418-9300

(212) 213-0006


'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Savient Pharmaceuticals to Present at the Imperial Capital Healthcare Investor Forum
2. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2011 Results
3. Savient Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference
4. Savient Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference
5. Savient Pharmaceuticals Appoints David Y. Norton Interim Chief Executive Officer
6. Savient Pharmaceuticals Appoints Experienced Pharmaceutical Executive, David Veitch as President of Savient Europe
7. Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA®
8. Savient Pharmaceuticals to Present at the Noble Financial Capital Markets Eighth Annual Equity Conference
9. Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting
10. Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results
11. Savient Pharmaceuticals to Hold Third Quarter 2011 Financial Results Conference Call on Thursday, November 3, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2020)... ... ... When Sean Fitzgerald was in business leadership for a national in-home care franchise, he ... needed to keep older adults in their homes, but it was hard to find ... in a position to help provide those property maintenance and repair services as the ...
(Date:5/28/2020)... ... May 28, 2020 , ... This new ... recipients. , “Notify.com is an acknowledgement-based notification platform,” said Bob Lueth, President of ... a PUSH notification, SMS text message, Email or Voice phone call—will be tracked ...
(Date:5/26/2020)... ... ... of tirelessly building an app to help people maintain social distance, the team at Regulr ... and release it to the public. Why? Because if they don't, it will only help ... in Richmond, VA by Stephen Dodge with the mission of creating the next generation of ...
Breaking Medicine Technology:
(Date:5/26/2020)... ... May 26, 2020 , ... ... infections can impact the brain causing post infectious encephalitis. The work was ... Infections) and PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) could adversely attack the central ...
(Date:5/26/2020)... NEW YORK (PRWEB) , ... May 26, 2020 ... ... due to the coronavirus pandemic, medical centers across the United States are joining ... front-line health care workers who have worked tirelessly to save lives. #FitForTheFrontLine is ...
(Date:5/21/2020)... Minn. (PRWEB) , ... May 21, 2020 , ... ... medical device manufacturer, announces its first milestone to deliver over one million FDA-compliant ... eight weeks. Summit Medical Face Shields meet the critical need for personal protective ...
(Date:5/21/2020)... Ga. (PRWEB) , ... May 21, 2020 , ... Friends ... District 35, has been endorsed by Planned Parenthood Southeast Advocates (PPSEA). ... who support family planning and the full range of reproductive health care. PPSEA educates ...
(Date:5/21/2020)... (PRWEB) , ... May 21, 2020 , ... ... its award-winning population health management platform that supports care management and utilization management ... 100 individuals at client sites, TruCare 2020 provides significant usability and automation upgrades ...
Breaking Medicine News(10 mins):